ABC of monitoring drug therapy. Digoxin.

ABC of monitoring drug therapy. Digoxin.

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Aronson, J, Hardman, M
التنسيق:	Journal article
اللغة:	English
منشور في:	1992

مواد مشابهة

ABC of monitoring drug therapy. Why monitor drug therapy?
حسب: Aronson, J, وآخرون
منشور في: (1992)

ABC of monitoring drug therapy. Patient compliance.
حسب: Aronson, J, وآخرون
منشور في: (1992)

ABC of monitoring drug therapy. Theophylline.
حسب: Aronson, J, وآخرون
منشور في: (1992)

ABC of monitoring drug therapy. Phenytoin.
حسب: Aronson, J, وآخرون
منشور في: (1992)

ABC of monitoring drug therapy. Measuring plasma drug concentrations.
حسب: Aronson, J, وآخرون
منشور في: (1992)

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
حسب: Aronson, J, وآخرون
منشور في: (1978)

Monitoring digoxin therapy: III. How useful are the nomograms?
حسب: Aronson, J
منشور في: (1978)

ABC of monitoring drug therapy. Lithium.
حسب: Aronson, J, وآخرون
منشور في: (1992)

ABC of monitoring drug therapy. Cyclosporin.
حسب: Reynolds, D, وآخرون
منشور في: (1992)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
حسب: Aronson, J, وآخرون
منشور في: (1977)

ABC of monitoring drug therapy. Aminoglycoside antibiotics.
حسب: Aronson, J, وآخرون
منشور في: (1992)

Digoxin revisited.
حسب: Aronson, J
منشور في: (1998)

Drug therapy monitoring (TDM) of Digoxin: safety and efficacy review
حسب: Rony Abdi Syahputra, وآخرون
منشور في: (2022-04-01)

ABC of monitoring drug therapy. Making the most of plasma drug concentration measurements.
حسب: Reynolds, D, وآخرون
منشور في: (1993)

Interaction of digoxin with quinine.
حسب: Aronson, J, وآخرون
منشور في: (1981)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
حسب: S. F. Zadvorev, وآخرون
منشور في: (2018-05-01)

Clinical pharmacokinetics of digoxin 1980.
حسب: Aronson, J
منشور في: (1980)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
حسب: Aronson, J, وآخرون
منشور في: (1977)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
حسب: Ford, A, وآخرون
منشور في: (1979)

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE
حسب: Aronson, J, وآخرون
منشور في: (1983)

Indications for the measurement of plasma digoxin concentrations.
حسب: Aronson, J
منشور في: (1983)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
حسب: M Yurdakök, وآخرون
منشور في: (1989-10-01)

Appropriateness of digoxin level monitoring
حسب: MR Mordasini, وآخرون
منشور في: (2002-09-01)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
حسب: Aronson, J, وآخرون
منشور في: (1980)

In vivo cation transport during short-term and long-term digoxin therapy.
حسب: Boon, N, وآخرون
منشور في: (1986)

EVIDENCE THAT CATION-TRANSPORT INVIVO IS INHIBITED BY SHORT-TERM BUT NOT LONG-TERM DIGOXIN THERAPY
حسب: Boon, N, وآخرون
منشور في: (1984)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
حسب: Ford, A, وآخرون
منشور في: (1979)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
حسب: Pugh, S, وآخرون
منشور في: (1982)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
حسب: Aronson, J, وآخرون
منشور في: (1982)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
حسب: Sophia Sheikh, وآخرون
منشور في: (2024-06-01)

Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods
حسب: Isabel Cristina Medeiros Barros, وآخرون
منشور في: (2014-01-01)

Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care
حسب: Emma M García-Iranzo, وآخرون
منشور في: (2017-07-01)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
حسب: Zeynep ÖZTÜRK, وآخرون
منشور في: (2018-01-01)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
حسب: Antonella Colella, وآخرون
منشور في: (2022-06-01)

Monitoring drug therapy.
حسب: Buclin, T, وآخرون
منشور في: (2012)

Neglected facts in digoxin intoxication
حسب: Sibel Ocak Serin
منشور في: (2017-06-01)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
حسب: Marcin Wais, وآخرون
منشور في: (2024-04-01)

Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
حسب: Tadej Petreski, وآخرون
منشور في: (2023-08-01)

Abc3-mediated efflux of an endogenous digoxin-like steroidal glycoside by magnaporthe oryzae is necessary for host invasion during blast disease
حسب: Patkar, Rajesh N., وآخرون
منشور في: (2013)

Abc3-mediated efflux of an endogenous digoxin-like steroidal glycoside by Magnaporthe oryzae is necessary for host invasion during blast disease.
حسب: Rajesh N Patkar, وآخرون
منشور في: (2012-01-01)